Clinical Trial Update: An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial assessing two doses of intra-articular Ampion for knee osteoarthritis completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Ampion

Snippet

Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2022-06-30